Cyclooxygenase-2 and Colorectal Cancer Chemoprevention: The β-Catenin Connection
Open Access
- 1 December 2006
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 66 (23) , 11085-11088
- https://doi.org/10.1158/0008-5472.can-06-2233
Abstract
Colorectal cancer poses a major clinical challenge in the developed world where this disease is common. Recent findings suggest that the prostaglandin E2, the proinflammatory product of elevated cyclooxygenase-2 activity in colon cancer, stimulates cancer cell growth through a G protein–dependent signaling pathway coupling the prostaglandin EP2 receptor to β-catenin control. These findings provide new insights into the molecular framework needed to evaluate chemopreventive strategies for colorectal cancer. (Cancer Res 2006; 66(23): 11085-8)Keywords
This publication has 39 references indexed in Scilit:
- CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancerThe Journal of Experimental Medicine, 2006
- Prostaglandin E2 Regulates the Nuclear Receptor NR4A2 in Colorectal CancerJournal of Biological Chemistry, 2006
- Microsomal prostaglandin E2 synthase‐1 in breast cancer: a potential target for therapyThe Journal of Pathology, 2005
- Killing time for cancer cellsNature Reviews Cancer, 2005
- COX-2: A Molecular Target for Colorectal Cancer PreventionJournal of Clinical Oncology, 2005
- Smoldering and polarized inflammation in the initiation and promotion of malignant diseaseCancer Cell, 2005
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Cancer genes and the pathways they controlNature Medicine, 2004
- Prostaglandin E2 stimulates colon cancer cell growth through induction of amphiregulinGastroenterology, 2003
- Where is APC going?The Journal of cell biology, 2001